Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1928 2
1946 5
1948 1
1950 1
1951 2
1952 2
1953 2
1954 2
1955 1
1958 1
1959 1
1962 1
1966 1
1968 1
1970 1
1975 1
1976 1
1977 3
1978 1
1979 6
1980 4
1981 6
1982 3
1983 6
1984 10
1985 8
1986 5
1987 11
1988 14
1989 9
1990 13
1991 9
1992 11
1993 15
1994 17
1995 14
1996 17
1997 18
1998 16
1999 22
2000 15
2001 9
2002 20
2003 13
2004 24
2005 27
2006 29
2007 29
2008 35
2009 26
2010 36
2011 32
2012 21
2013 26
2014 35
2015 39
2016 32
2017 36
2018 43
2019 27
2020 37
2021 37
2022 37
2023 17
2024 25
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

887 results

Results by year

Filters applied: . Clear all
Page 1
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial.
Ahmed N, Brawley V, Hegde M, Bielamowicz K, Kalra M, Landi D, Robertson C, Gray TL, Diouf O, Wakefield A, Ghazi A, Gerken C, Yi Z, Ashoori A, Wu MF, Liu H, Rooney C, Dotti G, Gee A, Su J, Kew Y, Baskin D, Zhang YJ, New P, Grilley B, Stojakovic M, Hicks J, Powell SZ, Brenner MK, Heslop HE, Grossman R, Wels WS, Gottschalk S. Ahmed N, et al. Among authors: gee a. JAMA Oncol. 2017 Aug 1;3(8):1094-1101. doi: 10.1001/jamaoncol.2017.0184. JAMA Oncol. 2017. PMID: 28426845 Free PMC article. Clinical Trial.
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial.
Hegde M, Navai S, DeRenzo C, Joseph SK, Sanber K, Wu M, Gad AZ, Janeway KA, Campbell M, Mullikin D, Nawas Z, Robertson C, Mathew PR, Zhang H, Mehta B, Bhat RR, Major A, Shree A, Gerken C, Kalra M, Chakraborty R, Thakkar SG, Dakhova O, Salsman VS, Grilley B, Lapteva N, Gee A, Dotti G, Bao R, Salem AH, Wang T, Brenner MK, Heslop HE, Wels WS, Hicks MJ, Gottschalk S, Ahmed N. Hegde M, et al. Among authors: gee a. Nat Cancer. 2024 Jun;5(6):880-894. doi: 10.1038/s43018-024-00749-6. Epub 2024 Apr 24. Nat Cancer. 2024. PMID: 38658775 Free PMC article. Clinical Trial.
Porphyrin-fused graphene nanoribbons.
Chen Q, Lodi A, Zhang H, Gee A, Wang HI, Kong F, Clarke M, Edmondson M, Hart J, O'Shea JN, Stawski W, Baugh J, Narita A, Saywell A, Bonn M, Müllen K, Bogani L, Anderson HL. Chen Q, et al. Among authors: gee a. Nat Chem. 2024 Jul;16(7):1133-1140. doi: 10.1038/s41557-024-01477-1. Epub 2024 Mar 8. Nat Chem. 2024. PMID: 38459234 Free PMC article.
Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation.
Tzannou I, Papadopoulou A, Naik S, Leung K, Martinez CA, Ramos CA, Carrum G, Sasa G, Lulla P, Watanabe A, Kuvalekar M, Gee AP, Wu MF, Liu H, Grilley BJ, Krance RA, Gottschalk S, Brenner MK, Rooney CM, Heslop HE, Leen AM, Omer B. Tzannou I, et al. Among authors: gee ap. J Clin Oncol. 2017 Nov 1;35(31):3547-3557. doi: 10.1200/JCO.2017.73.0655. Epub 2017 Aug 7. J Clin Oncol. 2017. PMID: 28783452 Free PMC article. Clinical Trial.
Bone marrow metastases.
Shpall EJ, Gee AP, Hogan C, Cagnoni P, Gehling U, Hami L, Franklin W, Bearman SI, Ross M, Jones RB. Shpall EJ, et al. Among authors: gee ap. Hematol Oncol Clin North Am. 1996 Apr;10(2):321-43. doi: 10.1016/s0889-8588(05)70341-5. Hematol Oncol Clin North Am. 1996. PMID: 8707758 Review.
887 results